# A Comparison of the Pharmacokinetics, Safety and Tolerance of Two Formulations of a Liquid IVIg in Healthy Volunteers

> **NCT02246855** · PHASE1 · COMPLETED · sponsor: **Bio Products Laboratory**

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Gammaplex® (Human Normal Immunoglobulin)

## Key facts

- **NCT ID:** NCT02246855
- **Lead sponsor:** Bio Products Laboratory
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2004-12
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2018-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02246855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02246855, "A Comparison of the Pharmacokinetics, Safety and Tolerance of Two Formulations of a Liquid IVIg in Healthy Volunteers". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT02246855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*